For the protein pull-down studies, 1 μg of fluorescently labeled PDGF in 100 μL of PBS was incubated with increasing amount of the nanoparticles. The incubation was carried out at 37 °C for 5 min followed by centrifugation at 50 000g for 30 min. The amount of PDGF in the supernatant was then determined by fluorescent spectroscopy (POLAR star, BMG Lab tech). Protein-only controls showed that no PDGF pelleted under the centrifugation conditions. All experiments were performed in triplicate.
PDGF binding studies
For the protein pull-down studies, 1 μg of fluorescently labeled PDGF in 100 μL of PBS was incubated with increasing amount of the nanoparticles. The incubation was carried out at 37 °C for 5 min followed by centrifugation at 50 000g for 30 min. The amount of PDGF in the supernatant was then determined by fluorescent spectroscopy (POLAR star, BMG Lab tech). Protein-only controls showed that no PDGF pelleted under the centrifugation conditions. All experiments were performed in triplicate.
A trace level of background fluorescence in the supernatants was seen during the pull-down experiments, which was due to residual dye after desalting the samples. This background signal was subtracted from all of the fluorescence measurements when calculating the PDGF amounts. Nonspecific adsorption of PDGF to the tubes during the incubation was determined using a PDGF-only control. On the basis of the control
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experiments, the free PDGF was approximately 0.7 μg (i.e., 7 μg/mL), which was taken into account to calculate the total amount of available PDGF. After centrifugation, the amount of nanoparticle-bound PDGF was calculated by subtracting the amount of PDGF measured in the supernatant from the total PDGF.
The amount of bound PDGF (pmol) was plotted against the concentration of the PAA-MSNs (nM). The molarity of the PAA-MSNs and PDGF was determined using the nanoparticle density of 19.3 g/cm3 and PDGF molecular weight of 14.4 kDa. A binding saturation curve was fitted to the protein pull-down data. The binding affinities and maximal binding capacity were determined by nonlinear least-squares regression analysis (Prism 5, GraphPad Software) using the equation
where B is bound PDGF, Bmax is the maximum binding capacity, [NP] is the concentration of PAA-MSN, Kd is equilibrium binding constant, and h is the Hill coefficient.
For the competition assay, a slight excess amount of each nanoparticle (60 nm = 17.7 nM; 70 nm = 16 nM; 80 nm = 8.2 nM; 90 nm = 5.2 nM; 100 nm = 4 nM) was incubated with 1 μg of fluorescently labeled PDGF at 37 °C for 5 min. After the initial incubation, 100-fold excess unlabeled PDGF was added and incubated at 37 °C for up to 240 min. At different time points, individual samples were centrifuged, and the amount of the labeled PDGF in the supernatants was determined as described above. Separate samples were used at each time point. A one-phase exponential decay curve was used to model the dissociation of the PDGF from the nanoparticle surface. The dissociation rate constants, Koff, of the protein-nanoparticle complexes were determined by fitting the equation to the data:
where Y is the bound PDGF (% total), t is time (min), and Koff is the dissociation rate constant (min -1 ). All of the experiments were performed in triplicate. 
Synthesis of Pt (IV)-based prodrug

Synthesis of mesoporous silica nanoparticles MSN
The nanomaterials intricate in this work were mesoporous silica nanoparticles (MSN) and modified MSN. The MSN synthesis was reported some minor modification. 2 First, 1 g of Poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) (EO20PO70EO20) copolymer (typical Mn 5800, denoted P123) as a template was stirred with anhydrous sodium sulfate (1.2 g) in a buffer solution (HAc-NaAc, pH=5, 0.2 M, 25 g) at room temperature (25° C) for 12 hr. The solution was then heated to 40° C. Tetraethyl orthosilicate (TEOS, 1.5 mL) as a silica source was added into the P123 solution under stirring and the mixed solution was kept in static condition for 24 hr. After that, the crude product was transferred to an agitated reactor for another 24 hrs hydrothermal reaction at 100° C. In the fourth step, the purified MSN products were baked at 500 °C for 5 hr.
For the amino-modification of MSN (MSN-NH 2 ), 1.5 mg of calcined MSN was dried and degassed at 110° C, and then suspended in 30 g of waterless toluene. To control the reaction rate, 2 mL of (3-aminopropyl) trimethoxysilane (APETS) was slowly added into the above slurry under stirring when the temperature was raised to 110° C. The slurry was stirred and refluxed at 24 hr. The resulting solid was collected and washed by toluene, dichloromethane, and ethanol, sequentially, and then dried at 70 °C. EDC for 10 min at room temperature in DMSO (6 ml), and then it was added to welldispersed amine functionalized MSN@NH 2 (0.2 mM) in DMSO (6 ml). The mixture was stirred at room temperature for 1 day, followed by centrifugation and sequential washing with DMSO, a water/methanol mixture and water. Cisplatin prodrugs to measure the amount of Pt in the prodrug, a previously reported Pt quantification method was adopted, modified and applied in this study.
Synthesis of Cisplatin prodrug-MSN conjugates
Synthesis of Poly acrylic acid coted cisplatin prodrug conjugates MSN
MSN@NH 2 @cis-DDP (30 mg) was dispersed in 10 mL of DMF, and then 10 mg of PAA (Mw = 1800) was dissolved into the mixture. The reaction mixture was stirred at 140° C for 2 h. After the reaction, the mixture was centrifuged and washed with copious ethanol. To ensure that the PAA physically adsorbed on MSN was removed completely, the washing procedure was repeated until the weight loss of PAA-MSN did not change.
The resultant product was dried overnight in a vacuum at 45º C.
General Instruments
The fluorescence emission spectra were obtained using a Shimadzu RF-5301PC
spectrofluorophotometer. 1H NMR spectra were recorded on a Bruker AVANCE-400 
Supporting Figures
Scheme S1. MSNs, cisplatin prodrug conjugated to the predominantly within the inner pore MSN surface and prodrug are electrostatically repulsive with affinity probe (PAA) were synthesized via a multistep procedure as depicted. increasing diameter suggests an increase in the number of molecular interactions between the protein and the nanoparticles as surface area increased. Under these conditions of excess PDGF, no aggregation of the nanoparticles was observed. Fig. 1c illustrates the loss of surface-bound fluorescently labelled protein over 5 h. As the size of the nanoparticles increased, the rate of dissociation decreased, which further suggests greater molecular interaction between the PDGF with the larger nanoparticles. In the absence of excess protein, less desorption of PDGF from any of the nanoparticles was observed. This is most likely due to rapid reabsorption when no competing protein is present in the medium. The dissociation rate constant (koff) was estimated by fitting an exponential decay curve of the data. As the size of the PAA-MSNs increased, koff decreased from almost 1 h-1 to less than 0.1 h-1. The association rate constant (kon), calculated as the ratio of koff to Kd, was essentially independent of nanoparticle size, except for the 60 nm PAA-MSNs were kon was approximately 2-fold higher. With maximum binding capacity, the stoichiometry between the bound fibrinogen and the nanoparticles was dependent on particle size Fig. 1d . 
